Zeo ScientifiX Past Earnings Performance

Past criteria checks 0/6

Zeo ScientifiX's earnings have been declining at an average annual rate of -0.3%, while the Biotechs industry saw earnings growing at 19.3% annually. Revenues have been growing at an average rate of 16.5% per year.

Key information

-0.3%

Earnings growth rate

14.3%

EPS growth rate

Biotechs Industry Growth17.0%
Revenue growth rate16.5%
Return on equityn/a
Net Margin-94.7%
Last Earnings Update31 Jul 2024

Recent past performance updates

No updates

Recent updates

Revenue & Expenses Breakdown

How Zeo ScientifiX makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

OTCPK:ZEOX Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Jul 245-590
30 Apr 245-590
31 Jan 245-6100
31 Oct 235-7110
31 Jul 235-9130
30 Apr 235-10140
31 Jan 236-10150
31 Oct 226-9150
31 Jul 227-7130
30 Apr 226-612-1
31 Jan 226-6120
31 Oct 216-13180
31 Jul 215-17210
30 Apr 214-21241
31 Jan 214-20230
31 Oct 203-13150
31 Jul 203-8100
30 Apr 202-350
31 Jan 202-240
31 Oct 192-230
31 Jul 191-140
30 Apr 191-120
31 Jan 191-450
31 Oct 181-350
31 Jul 181-450
30 Apr 181-560
31 Jan 181-560
31 Oct 171-990
31 Jul 170-880
30 Apr 170-880
31 Jan 170-550
31 Oct 160-110
31 Jul 160-110
30 Apr 160-110
31 Jan 160-110
31 Oct 150-110
31 Jul 150000
30 Apr 150000
31 Jan 150000
31 Oct 140000
31 Jul 140000
30 Apr 140000
31 Jan 140000

Quality Earnings: ZEOX is currently unprofitable.

Growing Profit Margin: ZEOX is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: ZEOX is unprofitable, and losses have increased over the past 5 years at a rate of 0.3% per year.

Accelerating Growth: Unable to compare ZEOX's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: ZEOX is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (16.6%).


Return on Equity

High ROE: ZEOX's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 11:00
End of Day Share Price 2024/12/20 00:00
Earnings2024/07/31
Annual Earnings2023/10/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Zeo ScientifiX, Inc. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Ishan MajumdarBaptista Research